Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene

(Mayo Clinic) Research by investigators at Mayo Clinic Cancer Center suggests that physicians should screen patients with lung cancer for MET amplification/overexpression before determining a treatment strategy. Their findings are published Cancer Discovery, a journal of the American Association for Cancer Research.